These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 30513203)

  • 1. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
    Lakhal S; Wood MJ
    Bioessays; 2011 Oct; 33(10):737-41. PubMed ID: 21932222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
    Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
    Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.
    Liang Y; Iqbal Z; Lu J; Wang J; Zhang H; Chen X; Duan L; Xia J
    Mol Ther; 2023 May; 31(5):1207-1224. PubMed ID: 36245129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics.
    Morishita M; Takahashi Y; Nishikawa M; Takakura Y
    J Pharm Sci; 2017 Sep; 106(9):2265-2269. PubMed ID: 28283433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics.
    Tenchov R; Sasso JM; Wang X; Liaw WS; Chen CA; Zhou QA
    ACS Nano; 2022 Nov; 16(11):17802-17846. PubMed ID: 36354238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progresses in exosome-based systems for targeted drug delivery to the brain.
    Bashyal S; Thapa C; Lee S
    J Control Release; 2022 Aug; 348():723-744. PubMed ID: 35718214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exosome-Mediated Small RNA Delivery For Gene Therapy].
    Sun W; Cao FJ; Wang N; Zhou Y; Ba Y; Zhang CY
    Sheng Li Ke Xue Jin Zhan; 2016 Jun; 47(3):162-7. PubMed ID: 29888878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives.
    Ahmed W; Mushtaq A; Ali S; Khan N; Liang Y; Duan L
    ACS Biomater Sci Eng; 2024 Oct; 10(10):5960-5976. PubMed ID: 38940421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake.
    Kimiz-Gebologlu I; Oncel SS
    J Control Release; 2022 Jul; 347():533-543. PubMed ID: 35597405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J; Fuente Freire M
    Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges.
    Kibria G; Ramos EK; Wan Y; Gius DR; Liu H
    Mol Pharm; 2018 Sep; 15(9):3625-3633. PubMed ID: 29771531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells.
    Reynolds JL; Mahajan SD
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):554-563. PubMed ID: 31823250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.